Palmoplantar Pustulosis Study (19 – 22 Weeks)

For condition: Palmoplantar Pustulosis

Palmoplantar Pustulosis Study (19 – 22 Weeks)

Study Summary

Who Can Participate?
Adults aged 18 years or above

Inclusion Criteria
• Has mild to severe PPP current condition defined by:
• Disease duration of PPP of > 6 months before randomisation.
• PPP-PGA of at least mild severity (PPP-PGA ≥2)
• Palmoplantar Pustulosis Area and Severity Index (PPPASI) ≥ 8
• Has Presence of ≥ 5 well-demarcated fresh pustules (white or yellow pustules) in total across all affected areas

Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating palmoplantar pustulosis (9 visits)
• Will receive an investigative topical treatment (study drug)
• Reimbursement for study-related expenses may be provided

How Long Will The Study Last?
• 19 – 22 weeks

Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial